Europe In-Vitro Toxicology Testing Market

European In-Vitro Toxicology Testing Market Size (2022 to 2027)

The size of the In-vitro toxicology testing market in Europe is expected to reach USD 12128.43 Million by 2027 from USD 6597.41 Million in 2022, growing at a CAGR of 12.95% during the forecast period.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is essential in drug discovery as it identifies the poisonous effects of a new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Increasing chronic diseases, growing aging population, rising technological advancements, growing demand for a healthy lifestyle, availability of government-supported anti-animal testing laws, and the existence of favorable regulatory policies (such as European government banned the production & sale of all animal-tested cosmetics in Europe) are driving the growth of in-vitro toxicology testing market in Europe. However, the high cost of technologies and lack of awareness on the in-vitro toxicology testing utilization are restraining the growth of the in-vitro toxicology testing market in Europe.

This research report segmented and sub-segmented into the following categories:

• By Product: Assays, Reagents & Labware and Services
• By Type: ADME, Dose and Toxic Substance
• By Toxicity Endpoints & Tests: Carcinogenicity, Dermal Toxicity and Genotoxicity
• By Technology: OMICS Technologies and Cell Culture Technology
• By Method: Cellular Assays and In-Silico Method
• By Industry: Cosmetics & Household Products and Pharmaceutical
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Based on product type, the Assays segment is estimated to command the largest share of Europe in-vitro toxicology testing market by product in 2019. Systemic toxicity is assessed to control Europe's largest share in-vitro toxicology testing market by toxicity endpoints & tests in 2019. Technology is further segmented as OMICS technologies & cell culture technology.

Based on Method, the In-silico method is estimated to command the largest share of Europe in-vitro toxicology testing market by the method in 2016. The cosmetics & household products industry is expected to account for the largest market share of Europe in-vitro toxicology testing market by industry in 2019.

Based on the region, Germany is estimated to account for the largest share of the Europe in-vitro toxicology testing market in 2019. In contrast, France is expected to grow at the highest CAGR during the forecast period.

Companies dominating European In-Vitro Toxicology Market profiled in this report are Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.) and Cyprotex (U.K.).